📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Temozolomide Nonresponsiveness in Aggressive Prolactinomas and Carcinomas: Management and Outcomes. (2022)

First Author: Das L

Attributed to: The effect of AIP mutations on the apoptotic RET pathway in pituitary adenomas funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1210/jendso/bvab190

PubMed Identifier: 35059545

Publication URI: http://europepmc.org/abstract/MED/35059545

Type: Journal Article/Review

Volume: 6

Parent Publication: Journal of the Endocrine Society

Issue: 2

ISSN: 2472-1972